McAdam LLC’s Celestica CLS Stock Holding History

McAdam LLC’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+700	New	+$263K	0.01%	422

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

McAdam LLC's CLS Position: Q2 2026 in Review

McAdam LLC opened a new position in Celestica (CLS) in Q2 2026: 700 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #422 among its holdings.

873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

McAdam LLC held 700 shares of Celestica worth $255K as of Q2 2026.
Celestica was a new McAdam LLC position in Q2 2026.
Celestica made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #422 holding.
873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.